URVASHI PATEL: Open Payments
NPI 1093438822 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $388 · 2025 $1,396
Food & beverage: $1,396
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $368 |
| Neurocrine BioSciences, Inc. | 2 | $246 |
| Otsuka America Pharmaceutical, Inc. | 3 | $147 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| Indivior Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $107 |
| E.R. Squibb & Sons, L.L.C. | 1 | $84 |
| ABBVIE INC. | 5 | $72 |
Products named: CAPLYTA, INGREZZA, REXULTI, INVEGA SUSTENNA, SUBLOCADE, LYBALVI, UZEDY, COBENFY.
Industry payments across OH — which companies pay providers there.
